D’Anna, Giulio
Zarbo, Cristina
Cardamone, Giuseppe
Zamparini, Manuel
Calza, Stefano
Rota, Matteo
Correll, Christoph U.
Rocchetti, Matteo
Starace, Fabrizio
de Girolamo, Giovanni http://orcid.org/0000-0002-1611-8324
Barlati, Stefano
Baroncelli, Andrea
Besana, Filippo
Boero, Maria Elena
Clerici, Massimo
Di Michele, Vittorio
Durbano, Federico
Foia, Maria Gabriella
Impicci, Stefania
Jacoponi, Filippo Maria
Leuci, Emanuela
Malagamba, Daniela
Marina, Marina
Martinelli, Alessandra
Monzani, Emiliano
Nappi, Gaetano
Piccicacchi, Benedetto
Placenti, Roberto
Rippa, Arturo
Tura, Giambattista
Zizolfi, Salvatore
,
Funding for this research was provided by:
Ministero della Salute (RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514, RF-2018-12365514)
Article History
Received: 21 March 2023
Accepted: 26 June 2023
First Online: 21 September 2023
Competing interests
: C.U.C. has been a consultant and/or advisor to or has received honoraria from: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Boehringer-Ingelheim, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Denovo, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Seqirus, SK Life Science, Sunovion, Sun Pharma, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, Denovo, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Mindpax, LB Pharma, and Quantic. The other authors declare that they have no competing interests.
: The study has been approved by the ethical committees (ECs) of the three main participating centres: EC of IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (31/07/2019; no. 211/2019), EC of Area Vasta Emilia Nord (25/ 09/2019; no. 0025975/19), and EC of Pavia (02/09/2019, no. 20190075685), and by the ECs of all participating sites.